Taylorella equigenitalis antibody and antigen (recombinant protein)

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-VT-P135-Tg001-Ag01	Recombinant Taylorella equigenitalis protein	3090
GMP-VT-P135-Tg001-Ab01	Anti-Taylorella equigenitalis mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P135-Tg001-Ab02	Anti-Taylorella equigenitalis mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P135-Tg001-Ab03	Anti-Taylorella equigenitalis mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P135-Tg001-Ab04	Anti-Taylorella equigenitalis mouse monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-VT-P135-Tg001-Ag01
Product Name	Recombinant Taylorella equigenitalis protein
Pathogen	Taylorella equigenitalis
Target/Biomarker
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Taylorella equigenitalis antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Taylorella equigenitalis level test of animal Equine/Horse with Taylorella equigenitalis infection.
Tag	His
Products description	Recombinant Taylorella equigenitalis protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-VT-P135-Tg001-Ab01, GMP-VT-P135-Tg001-Ab02, GMP-VT-P135-Tg001-Ab03, GMP-VT-P135-Tg001-Ab04
Product Name	Anti-Taylorella equigenitalis mouse monoclonal antibody (mAb)
Pathogen	Taylorella equigenitalis
Target/Biomarker
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Taylorella equigenitalis antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Taylorella equigenitalis antibodies in Taylorella equigenitalis level test of animal Equine/Horse with Taylorella equigenitalis infection.
Tag	mFc
Products description	Anti-Taylorella equigenitalis mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Taylorella equigenitalis is a small, slow-growing (3–7 days on specialized hemolyzed blood agar), Gram-negative, microaerophilic, catalase-positive, oxidase-positive but otherwise biochemically unreactive coccobacillus. It is the cause of contagious equine metritis (CEM), which was first defined in Newmarket in 1977. It causes epidemic acute endometritis, with clinical signs varying from a copious mucoid/gray vaginal discharge, which may be first seen as early as 2 days after mating, to no gross signs of abnormality. The acute endometritis usually causes conception failure, but some mares resolve the acute infection soon enough to allow conception and normal pregnancy to proceed. Taylorella equigenitalis is transmitted by either carrier stallions or mares directly during mating or by indirect genital contact with contaminated fomites (vaginal speculums, artificial vagina, or wash buckets).1 There is evidence that transmission of T. equigenitalis through the use of fresh cooled or extended semen (with antibiotics) from an infected stallion is possible2 but most likely infrequent.

About GDU